These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26176968)

  • 1. Advances in imaging of cardiopulmonary involvement in sarcoidosis.
    Kouranos V; Hansell DM; Sharma R; Wells AU
    Curr Opin Pulm Med; 2015 Sep; 21(5):538-45. PubMed ID: 26176968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies.
    Sharma S
    Curr Opin Pulm Med; 2009 Sep; 15(5):507-12. PubMed ID: 19542892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac sarcoidosis: seven keypoints to remind in order to avoid misdiagnosis].
    Porretta AP; Van der Gucht A; Bisch L; Mitsakis P; Pomoni A; Allenbach G; Lalonde MN; Schaefer N; Buss G; Prior JO; Pruvot É
    Rev Med Suisse; 2016 May; 12(520):1035-6, 1038-41. PubMed ID: 27424343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-technique imaging of sarcoidosis.
    Balan A; Hoey ET; Sheerin F; Lakkaraju A; Chowdhury FU
    Clin Radiol; 2010 Sep; 65(9):750-60. PubMed ID: 20696303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.
    Pandya C; Brunken RC; Tchou P; Schoenhagen P; Culver DA
    Eur Respir J; 2007 Feb; 29(2):418-22. PubMed ID: 17264327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
    Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
    Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
    J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET for gauging of sarcoid disease activity.
    Adams H; Keijsers RG; Korenromp IH; Grutters JC
    Semin Respir Crit Care Med; 2014 Jun; 35(3):352-61. PubMed ID: 25007087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced imaging of cardiac sarcoidosis.
    Schatka I; Bengel FM
    J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
    Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
    Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Cheriex EC; Gorgels AP; Crijns HJ
    Chest; 2005 Sep; 128(3):1629-37. PubMed ID: 16162768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sarcoidosis: challenges in clinical practice.
    Bakker AL; Grutters JC; Keijsers RG; Post MC
    Curr Opin Pulm Med; 2017 Sep; 23(5):468-475. PubMed ID: 28661904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ventricular late potentials in patients with pulmonary sarcoidosis.
    Yodogawa K; Seino Y; Ohara T; Iwasaki YK; Hayashi M; Miyauchi Y; Azuma A; Shimizu W
    Heart Rhythm; 2018 Jun; 15(6):798-802. PubMed ID: 29857850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoid Heart Disease: an Update on Diagnosis and Management.
    Masri SC; Bellumkonda L
    Curr Cardiol Rep; 2020 Oct; 22(12):177. PubMed ID: 33119794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the management of pulmonary sarcoidosis.
    Culver DA; Judson MA
    BMJ; 2019 Oct; 367():l5553. PubMed ID: 31641045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET scanning in sarcoidosis.
    Jain V; Hasselquist S; Delaney MD
    Ann N Y Acad Sci; 2011 Jun; 1228():46-58. PubMed ID: 21718322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sarcoidosis.
    Nunes H; Freynet O; Naggara N; Soussan M; Weinman P; Diebold B; Brillet PY; Valeyre D
    Semin Respir Crit Care Med; 2010 Aug; 31(4):428-41. PubMed ID: 20665393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.
    Lynch JP; Hwang J; Bradfield J; Fishbein M; Shivkumar K; Tung R
    Semin Respir Crit Care Med; 2014 Jun; 35(3):372-90. PubMed ID: 25007089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in radionuclide imaging of cardiac sarcoidosis.
    Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
    Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations.
    West SG
    Curr Opin Rheumatol; 2018 May; 30(3):243-248. PubMed ID: 29389828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.